AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide IV infusion will be administered as per the schedule specified in the respective arm.
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin
Description: Doxorubicin IV infusion will be administered as per the schedule specified in the respective arm.
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Doxorubicin IV infusion will be administered as per the schedule specified in the respective arm.
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vincristine
Description: Vincristine IV infusion will be administered as per the schedule specified in the respective arm.
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Description: Vincristine IV infusion will be administered as per the schedule specified in the respective arm.
Study NCT04647097 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard intervention only
Description: Standard intervention (SI) will be a part of standard care in all participating centers, and will be provided for all acute pancreatitis patients, who are hospitalized and their condition is alcohol induced. A specially trained study nurse will deliver the intervention, since they were found to be the most effective regarding the decrease in alcohol consumption and smoking. The cost- effectiveness of the intervention and the feasibility were also taken into account. The Assist-linked brief intervention according to the World Health Organization (WHO) will serve as the base for the intervention, with an avarage of 30 minutes, based on a review containing 69 randomized controlled trials, which concluded that longer intervention do not have additional benefit. The patients will be also educated about the disease course of acute pancreatitis during the standard intervention.
Study NCT04647097 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard intervention plus repeated intervention
Description: Standard intervention (SI) will be performed as described above. The repeated intervention will be delivered by the former mentioned same nurse and will be structured similarly to the standard intervention. Every visit and intervention will be individually altered according to the motivation of the patient, but they will follow the same structure. The sessions can be divided into three main parts: first, highlighting the harmful effects of smoking and alcohol on the pancreatic functions. Secondly, a discussion about the motivation of the patient will happen. The last portion of the session will focus on the responsibility of the individual to reach the desired goal will be highlighted. To enhance the efficacy of our intervention we wish to provide feed-back for the patient based on laboratory testing: the mean corpuscular volume (MCV) and gamma glutamyl-transferase (GGT) values will be measured right before the interview. The study nurse will not take part in patient care.
Study NCT05240365 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SDF modified Hall technique
Description: * Preparation for Hall technique and selection of the crown.~* Clinical application of SDF.~* Cementation of the selected crown.
Study NCT05240365 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional pulpotomy and stainless steel crown
Description: * Teeth will be anesthetized .~* Rubber dam will be used and high suction in pulpotomy procedure.~* Cavity outline will be performed by sterile #330 high speed bur using water spray.~* Caries will be removed by large spoon excavator.~* pulpal exposure will be occurred then the roof of pulp chamber will be removed by low speed round bur. Hemostasis will be obtained by applying pressure with moist cotton pellet with saline.~* Teeth will be treated by using sterile cotton pellet with formcresol for three to five min then, remove it.~* Pulp stumps of will be dressed with reinforced zinc oxide eugenol, IRM®\*~* Tooth Preparation will be done followed by placement of stainless-steel crown
Study NCT04338763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RP72
Description: RP72 is formulated as a sterile lyophilized powder which is reconstituted in sterile water for injection (WFI) prior to administration. IV injection of RP72 will be administered thrice weekly in the first 28-day treatment cycle (Cycle 1). RP72 will continue to be administered thrice weekly for 4 weeks for Cycle 2 and each subsequent 28-day treatment cycle.
Study NCT04338763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is an anti-cancer chemotherapy drug. IV infusion of Gemcitabine will be administered once weekly in the first 28-day treatment cycle (Cycle 1). Gemcitabine will continue to be administered once weekly for the first 3 weeks and then one week rest in Cycle 2 and each subsequent 28-day treatment cycle.
Study NCT05490940 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tisseel®
Description: The investigational medical product (IMP) in this study is Tisseel®, which is a tissue sealer consisting of two components:~1. Sealer protein: Human fibrinogen as glue component and synthetic Aprotinin, which delays fibrinolysis.~2. Human thrombin: Thrombin is an unique molecule that functions both as a procoagulant and anticoagulant. It activates platelets through its receptor on the platelets and regulates its own. generation by activating coagulation factors V, VIII and even XI resulting in a burst of thrombin formation.~Its indications are a better hemostasis, enforcement of vessel/gastrointestinal sutures and tissue sutures (mesh grafts, flaps etc).
Study NCT05945446 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Galectin 3
Description: Women diagnosed with Placenta Accreta Spectrum (PAS) were invited to join the study, providing they had no known systemic diseases (e.g. chronic hypertension, diabetes, hypothyroidism, chronic renal-liver diseases, etc.), autoimmune disorders, multiple pregnancies, or the presence of fetal structural and chromosomal anomalies. They also did not have cholestasis of pregnancy, preterm delivery, or evidence of chronic and active infection.
Study NCT04629651 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Captopril
Description: Oral, to be administered per the dose escalation scheme.
Study NCT05664178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-Resistance Training
Description: Tele-Resistance training sessions will be supervised and guided by a certified exercise trainer via smartphone, tablet or laptop. Exercises will be performed using resistance tubes (Bodylastics Resistance Bands Set) and a connectable bar (Bionic Body Workout Bar) that mimics a weighted barbell when tubes are attached. The tubes provide up to 142 pounds of resistance (adjustable in increments between 3-10 pounds) when simultaneously connected to handles or bar, and multiple tubes can be attached simultaneously. Participants will engage in brief warm up exercises lasting 2-3 minutes prior to each RT session and will rest at least 1 minute between sets of the same exercise to aid muscle recovery. Participants will perform at least 2 sets of 12 repetitions for each of 6 exercises. Including warm up, training sets, and rest, sessions will last approximately 30 minutes. RT will include six target exercises focusing on major muscle groups of the upper body, lower body, and core.
Study NCT04889989 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Microwave Ablation
Description: Percutaneous microwave ablation using the NeuWave Microwave Ablation System for non-small cell lung cancer or oligometastatic lung tumors
Study NCT05442801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclopentolate
Description: Well known eye drop used for cycloplegic refraction among children.
Study NCT05442801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tropicamide
Description: Well known eye drop used for cycloplegic refraction among children.
Study NCT05675098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Description: This medication is a psychostimulant medication and is usually prescribed for individuals with Attention-Deficit/Hyperactivity Disorder to manage ADHD behavioral symptoms
Study NCT05675098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Modafinil
Description: This medication is a Central Nervous System stimulant and is usually used to treat neurological conditions, including Narcolepsy
Study NCT05675098 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participant will receive placebo tablets (Methylphenidate and Modafinil shape)
Study NCT05581108 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Juice PLUS+® OMEGA
Description: Daily dose of total Omega blend: 925 mg (2 capsules)
Study NCT05581108 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matched placebo (2 capsules)
Study NCT05908136 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: restorative materials
Description: two types of composite with strip crown in primary molars
Study NCT06420752 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Calf Plantar flexion
Description: Daily passive calf stretching
Study NCT06420752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary nitrate
Description: Weekday 140 ml dietary nitrate consumption two hours prior to passive stretching
Study NCT06299345 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor imagery training
Description: MI for this study took the form of non-guided first-person mental practice. First-person imagery was explained to each participant where they imagined performing the target skill through their own eyes rather than if they were a bystander watching someone else do the task (third person).
Study NCT06299345 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: NO motor imagery training
Description: The participants performed the physical task only. It is a mirror tracing game that requires participants to trace a star shape viewed through a mirror, going as fast as possible while staying within the lines.
Study NCT06518811 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-Based Exercise Programme
Description: The asynchronous video-based telerehabilitation programme had a duration of eight weeks. The participants were instructed to perform the exercises on a regular basis, three days a week, with a time interval of 24 hours between each session. The exercises were to be performed using the instructional videos and recorded in the exercise diaries provided. The participants were used exercise balls and resistance bands distributed by the researchers according to exercise programme.
Study NCT05643950 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Foley catheter
Description: Silicone Foley catheters are transurethral balloon catheters used for the treatment of bladder emptying disorders, as well as for drainage of urine from the urinary tract, continuous fluid irrigation, and/or medication administration. Its use is suitable for a prolonged period of no more than 29 days and is used in Urology, Internal Medicine, Surgery, Obstetrics and Gynaecology Services.~For this study, conventional Foley-type catheters whose use is approved in Spain for routine use will be used. Silicone Foley catheters, usually available in 2- and 3-way, are made of silicone and consist of a body, drainage funnel, inflation funnel, irrigation funnel (if present, only on 3-way catheters) and balloon valve. The product is sterile and single use.
Study NCT05643950 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: T-Control catheter
Description: The T-control® catheter is a flexible, sterile silicone tube with an inflatable balloon at the distal tip, a polytetrafluroethylene membrane integrated into its body, and a sliding fluid control valve. The valve, built into the catheter, provides additional functions to the catheter, such as turning urine flow on and off after insertion (functions currently provided by accessories such as caps or valves) and controlling urination during the insertion process (function that is not provided by any other device). In this way, accidental loss of urine can be avoided from the first moment of use until its withdrawal. Additionally, it has a safety cap that reduces the possibility of accidental movements of the valve before use or during transport and fixing. The design has been developed in such a way that, once inserted, it facilitates autonomous use even for the elderly or patients with limited manual dexterity. The device is sterile and single use, like any conventional Foley catheter.
Study NCT05287893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyronaridine
Description: Single dose
Study NCT05287893 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: P. falciparum IBSM infection
Description: Induced Blood Stage Malaria
Study NCT06705153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laughter yoga
Description: Patients who come to the outpatient clinic will be met, informed about the study and written informed consent will be obtained from patients who agree to participate in the study. Patient information form will be applied, baseline measurements will be made (IBS-SSS, DAS-42, PSQI and IBS-QOL) and IBS type will be determined according to Bristol stool scale. Type 1-2 constipation, Type 6-7 diarrhea, Type 1 or Type 2 at the same time with Type 6 or Type 7 will be considered as mixed type IBS and those who do not fit any of the scales will be considered as unclassifiable IBS. A total of 8 sessions will be held with the patients in the intervention group in the form of meetings via zoom with the help of a smart cell phone/computer (2 weekly sessions). The meetings will be in 3 groups.
Study NCT06707623 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory Physiotherapy
Description: Physiotherapy will include: Progressive breathing retraining, neurosensory training, nose breathing training, activity modification, inhalation-exhalation ratio training, dynamic respiratory control training and instructions for continuing all of the above training at home. Total 5 sessions in 9 weeks time.
Study NCT06707623 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation
Description: Pulmonary Rehabilitation will be completed in 16 sessions (2 times a week for 8 weeks). It will combine exercise with breathing retraining guided by CPET findings regarding erratic breathing pattern and/or hyperventilation.
Study NCT06715891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raphamin
Description: Tablet for oral use.
Study NCT06583616 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Anion Gap
Description: Patient with acute pulmonary embolism who not survive after hospitalization
Study NCT06715891 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet for oral use.
Study NCT06724367 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transspinal direct current stimulation
Description: Direct current electrical stimulation applied non-invasively to the spinal cord.
Study NCT06724367 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: transspinal direct current stimulation simulated
Study NCT06530966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICP-332 Tablets
Description: Eligible patients will receive ICP-332 tablets orally as per the protocol
Study NCT06530966 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ICP-332 Placebo Tablets
Description: Eligible patients will receive ICP-332 placebo tablets orally as per the protocol
Study NCT06732713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Swiss Ball
Description: Swiss ball exercises will be performed in supine, sitting and standing position for about 25 to 30 minutes , 3 to 4 sessions per week for 8 weeks
Study NCT05214248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: a multimedia admission orientation
Description: A short video based on self-drawing characters and figures with Chinese dubbing and background light music, explaining the NICU environment, health care workers, and tests and examination that are essential for an infant admitted to this NICU of Cathay Hospital in Taipei, R.O.C.
Study NCT06732713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Frenkel exercise
Description: Frenkel exercises will be performed in supine, sitting and standing position for about 25 to 30 minutes, 3 to 4 sessions per week for 8 weeks
Study NCT06722742 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine only
Description: Inj: Ketamine given to group K following spinal anesthesia
Study NCT06309745 — intervention group
Intervention type: PROCEDURE
Intervention: retroperitoneal lymph node dissection
Description: retroperitoneal lymph node dissection
Study NCT06309745 — intervention group
Intervention type: DRUG
Intervention: Carboplatin AUC10
Description: Carboplatin AUC10
Study NCT06722742 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: Inj Tramadol given to group T following spinal anesthesia
Study NCT06754605 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCTV02
Description: Participants will receive a singe dose of SCTV02 on Day 0.
Study NCT06754605 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive a singe dose of Placebo on Day 0.
Study NCT06757322 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Singel Needle Double Cannula TMJ Arthrocentesis
Description: Artocentesis describes the lavage of the TMJ by introducing a saline/ringer lactate solution through a needle inserted into the upper joint cavity. TMJ arthrocentesis was first introduced as a double needle entry method by Nitzan et al in 1991. The single needle technique was developed by Singh and Varghese and introduced in 2013. The single needle method is a more simplified modification of the first method.
Study NCT06757322 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Double Needle TMJ Arthrocentesis
Description: Artocentesis describes the lavage of the TMJ by introducing a saline/ringer lactate solution through a needle inserted into the upper joint cavity. TMJ arthrocentesis was first introduced as a double needle entry method by Nitzan et al in 1991.
Study NCT06756425 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise program
Description: aerobic exercise program for 3 months with nutritional health awearness sessions
Study NCT06756425 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: nutritional health awareness sessions
Description: lifestyle changes and nutritional awareness sessions for 3 months twice a week for participants and their parents
Study NCT06754007 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ROPES Training Programme
Description: ROPES is a training programme that involves resistance training, whole-body exercises and HIIT aerobic sessions with each session lasting no longer than 45 minutes.
Study NCT06756672 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HPI guidance
Description: patients with HPI guidance
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Prednisone PO will be administered as per the schedule specified in the respective arm.
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone PO will be administered as per the schedule specified in the respective arm.
Study NCT06186258 — intervention group
Intervention type: DEVICE
Intervention: percutaneous pulmonary valve implantation (PPVI)
Description: The only inclusion criterion is a successful PPVI to treat RVOT dysfunction. Procedural techniques were at each operator's discretion as well as post-procedure treatments and patient's follow-up. As we sought to assess IE incidence during follow-up, patients who underwent catheterization for intended PPVI but who did not had a successful valve implantation were not included. Successful PPVI was defined as patient discharged alive without valve surgery after successful valve implantation in the RVOT.
Study NCT06756672 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: No HPI guidance
Description: patients without HPI guidance
Study NCT06757231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse Counseling Based on the Chronic Care Model (CCM)
Description: This intervention involves personalized nurse counseling for patients diagnosed with Inflammatory Bowel Disease (IBD) based on the Chronic Care Model. The intervention includes:~Biweekly phone consultations and weekly informational messages to provide education and support for symptom management, stress reduction, and quality-of-life improvement.~An educational booklet to aid self-management. Follow-ups to assess progress, address concerns, and provide guidance on IBD management strategies.
Study NCT06758440 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: chitosan
Description: Evaluate Effectiveness of hydroxyapatite reinforced chitosan hydrogel in modulation of osseintegration round immediate dental implant in a Randomized single blind control study
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib
Description: Orelabrutinib PO will be administered as per the schedule specified in the respective arm.
Study NCT05548582 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: OxyCODONE 5 mg Oral Tablet
Description: No opioid prescription after laparoscopic hysterectomy
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide PO will be administered as per the schedule specified in the respective arm.
Study NCT05351346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Decitabine IV infusion will be administered as per the schedule specified in the respective arm.